The lysyl oxidase-like protein 4 (LOXL4) is the latest member of the emerging family of lysyl oxidases, several of which were shown to function as copper-dependent amine oxidases catalyzing lysine-derived cross-links in extracellular matrix proteins.
INTRODUCTION
Lysyl oxidase (LOX) is a copper-dependent amine oxidase that oxidizes primary amine substrates to reactive aldehydes. In most tissues, LOX is responsible for the lysinederived cross-links in collagen and elastin, which is the essential step for biogenesis of a fibrillar extracellular matrix (1) . More recently, several new functions, as varied as tumor suppression, cellular senescence, developmental control and chemotaxis, have been assigned to this amine oxidase (2, 3, 4) . The importance of LOX has been further emphasized by the findings that abnormal LOX activity contributes to a number of different diseases including atherosclerosis, aortic aneurysms, pulmonary fibrosis and hepatic fibrosis (5) (6) (7) (8) (9) .
In recent years, four novel LOX-like proteins, LOXL, LOXL2, LOXL3 and LOXL4, have been identified, each containing the characteristic domains of LOX in the carboxy (C)-terminus, such as the copper-binding domain, the lysyl-tyrosyl-quinone (LTQ) residues and the cytokine receptor-like (CRL) domain (10) (11) (12) (13) (14) . The presence of a LOX family suggests that the multiple diverse functions currently attributed to a single enzyme, LOX, may be due to different LOX-like proteins. In addition to the conserved Cterminal domains, LOXL2, LOXL3 and LOXL4, unlike LOX and LOXL, contain four scavenger receptor cysteine rich (SRCR) domains in the amino (N)-terminus, forming a by guest on http://www.jbc.org/ Downloaded from subfamily within the LOX family. Based on the conservation of the C-terminal LOX domains, these SRCR domain-containing members were predicted to contain the amine oxidase function, but it has yet to be determined. SRCR domains are known to mediate ligand-binding in a number of secreted and receptor proteins (15, 16) . The presence of SRCR domains within LOXL2, LOXL3 and LOXL4 indicates that these three proteins may play novel functions possibly involving components of the extracellular matrix.
The murine homologue of LOXL4, reported as LOXC, was initially identified as a transcript specifically expressed in the cartilage (17) . However, Northern analyses of the human LOXL4 gene showed more ubiquitous expression in many tissues, but different from the other members of the LOX family (10, 14) , suggesting distinct tissue and substrate specificity of this protein. In this study, we report for the first time that LOXL4 functions as an active amine oxidase. The LOXL4 protein was expressed as His-tagged recombinant forms in inclusion bodies using an Escherichia coli expression vector, extracted with 8 M urea, and renatured into enzymatically active forms toward a nonpeptidyl substrate, benzylamine. The amine oxidase activity of LOXL4 was sensitive to -aminopropionitrile (BAPN), a well-known specific inhibitor of LOX.
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EXPERIMENTAL PROCEDURES
Construction of LOXL4 expression plasmids
The LOXL4 cDNAs were PCR-amplified from human placental total RNA (BD Biosciences) using Pfu turbo polymerase (Stratagene) according to the manufacturer's suggestions. The forward primers, LOXL4-p1, LOXL4-p2, LOXL4-p3, LOXL4-p4 and LOXL4-p5, were designed to start the open-reading frame of LOXL4 at The PCR-amplified DNA fragments were gel-purified and then ligated into pET21a
(Novagen) at Nhe I and Hind III restriction sites in frame with the C-terminal hexahistidine tag. All the resulting expression constructs, pET21a-LOXL4-p1, pET21a-LOXL4-p2, pET21a-LOXL4-p3, pET21a-LOXL4-p4 and pET21a-LOXL4-p5, were confirmed to contain the desired LOXL4 sequence by DNA-sequencing analysis using a
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Cycle Sequencing Ready Reaction kit (Applied Biosystems) according to the manufacturer's recommended method.
Expression and purification of the LOXL4 proteins
The E. coli strain BL21(DE3) (Novagen) was used for transformation of the pET21a-derived expression constructs of LOXL4. The transformants were grown in 1 L of LB medium containing 100 g/ml of ampicillin at 37 until the OD 600 of culture 
N-terminal Amino Acid Sequence Analysis
To confirm the N-terminal sequences of the recombinant LOXL4 proteins, the purified proteins were subjected to N-terminal analysis by Edman degradation. After purification by the nickel-chelating affinity chromatography, 5 g of each LOXL4-p2, LOXL4-p3, LOXL4-p4 and LOXL4-p5 was subjected to SDS-PAGE, transferred to polyvinylidene difluoride membranes (Hybond-P, Amersham Biosciences), and stained with Ponceau S.
The visualized protein bands were excised and loaded into a CLC Capillary 492
Sequencer (Applied Biosystems). The ten N-terminal residues of each purified recombinant protein were analyzed by the automated N-terminal sequencing, and all the recombinant LOXL4 proteins contained the expected sequences in the N-terminus.
Refolding of the LOXL4 proteins
For stepwise dialysis, the purified LOXL4 proteins were diluted to 100 g/ml in phosphate buffer (10 mM K 2 HPO 4 , pH 7.0). The protein samples were dialyzed overnight first against a buffer of 10 mM K 2 HPO 4 , pH 9.6, 200 M CuCl 2 and 2% sodium N-lauroylsarcosinate and then against a buffer of 10 mM K 2 HPO 4 , pH 9.6 and 5 9 M CuCl 2 . The proteins were further dialyzed twice against the phosphate buffer. The concentration of dialyzed protein samples was determined by the BCA method (18) .
After dialysis, the protein solutions were aliquoted and lyophilized in the presence of 10 mM trehalose using a Freeze dryer (Labconco).
Amine oxidase assays
Amine oxidase assays were performed using an UV-spectrophotometer (Kontron Instruments). The assay reactions included 10 mM benzylamine and 100 g of a recombinant LOXL4 protein in 1 ml of the phosphate buffer. The reaction mixtures were incubated at 37 with simultaneous detection at 250 nm. For the assays with BAPN, the LOXL4 protein was preincubated with 100 molar excess of BAPN in the phosphate buffer at 37 for 1 h, and then 10 mM benzylamine was added to the reaction mixture for amine oxidase assays.
RESULTS AND DISCUSSION
Expression of the LOXL4 proteins
In an effort to express and purify enzymatically active forms of LOXL4, we constructed a series of LOXL4 expression plasmids. The LOXL4 cDNAs of variable by guest on October 1, 2017
http://www.jbc.org/ Downloaded from lengths were PCR-amplified and cloned into pET21a, an E. coli expression plasmid. All the recombinant LOXL4 proteins were designed to contain the characteristic C-terminal domains of the LOX family, including the copper-binding domain, the CRL-domain and the LTQ residues (Lys 638 and Tyr 674 ). However, the recombinant proteins were designed to start at different residues, either encoding the full-length polypeptide of LOXL4 (LOXL4-p1) or subsequently deleting the four SRCR domains (LOXL4-p2, LOXL4-p3, LOXL4-p4, and LOXL4-p5) (Fig. 1A) .
Bone morphogenic protein-1 (BMP-1), also known as procollagen C-proteinase, was shown to proteolytically cleave the LOX and LOXL precursor proteins at Ala/GlyAsp, leaving an aspartic acid residue at the N-terminus of each processed protein (19, 20) . A potential cleavage site of BMP-1 was also identified within LOXL4, at residues Ala 569 -Asp 570 . The LOXL4-p5 expression construct was designed to correspond to this potentially processed form of LOXL4, deleting all the SRCR domains in the N-terminus.
Upon induction by 1 mM IPTG at 37 , the recombinant LOXL4 proteins, except for LOXL4-p1, were expressed at high levels from the expression constructs ( The apparent sizes of the expressed recombinant LOXL4 proteins were in good agreement with the deduced molecular mass; 62 kDa for LOXL4-p2, 50 kDa for LOXL4-p3, and 38 kDa for LOXL4-p4, and 22 kDa for LOXL-p5 (Fig. 1B) . The hexahistidine tagged recombinant LOXL4-proteins were over 95% pure on SDS-PAGE gels ( 12
Amine oxidase activity of the purified LOXL4 proteins
In an attempt to refold the proteins denatured by urea during purification, we tried stepwise dialysis in the presence of N-lauroylsarcosinate and Cu
2+
, an oxidative catalyzer. In the first dialysis buffer, 2% (w/v) sodium N-lauroylsarcosinate and 200 M of CuCl 2 were added. The second dialysis was carried out without any detergent but in the presence of 5 M CuCl 2 , and the protein samples were further dialyzed twice in the potassium phosphate buffer.
The refolded recombinant proteins were assessed for amine oxidase activity toward a nonpeptidyl substrate, benzylamine. One unit of amine oxidase activity was defined as the activity resulting in oxidation of 1 mol of benzylamine per min at 37 . The conversion of benzylamine substrate to benzaldehyde was monitored at 250 nm using spectrophotometry. The specific activity of LOXL4-p2, LOXL4-p3, LOXL4-p4 and LOXL4-p5 was 0.022 units/mg, 0.025 units/mg, 0.027 units/mg, and 0.032 units/mg, respectively ( Table 2 ). All these activities were inhibited to a background level by 100 molar excess of BAPN, an irreversible inhibitor of LOX (Table 2 ).
These specific activities of LOXL4 were similar to or even higher than the previously reported activities of LOX, 0.019 U/mg and 0.02 ~ 0.04 U/mg, performed with the LOX protein purified from the bovine aorta (22, 23 ). The differences in
13 specific activity within the tested recombinant proteins were primarily due to the differences in molar concentration of the recombinant proteins in the assays. These assay results indicated that all the rested recombinant proteins, including the potentially BMP-1 processed form of LOXL4, could function as an active amine oxidase toward benzyleamine and, moreover, that, the conserved C-terminal domains of LOXL4 were sufficient to confer amine oxidase function to this protein.
The SRCR domains in LOXL4
In our assays, the recombinant LOXL4 proteins containing one or more SRCR domains (LOXL4-p2, LOXL4-p3, and LOXL4-p4) showed BAPN-specific amine oxidase activity toward benzylamine (Table 2) In summary, the purpose of this study was to assess the amine oxidase activity of LOXL4. We have shown for the first time that LOXL4 functions as an amine oxidase and, furthermore, that the deletion of SRCR domains does not affect its amine oxidase activity. Availability of these enzymatically active forms of LOXL4 will be significantly helpful in further functional characterization of this latest member of amine oxidases, which should provide significant insights into understanding the mechanistic bases for the diverse functions played by the LOX family members. Table I Primers used for subcloning of LOXL4 cDNAs into pET21a
Figure Legends
The underlined letters indicate the unique restriction sites introduced for subcloning into pET21a. The backward primer was used for all the LOXL4 constructs. 
